Published in Am J Phys Anthropol on October 14, 2011
Facial surface morphology predicts variation in internal skeletal shape. Am J Orthod Dentofacial Orthop (2016) 0.75
The facial morphology in Down syndrome: A 3D comparison of patients with and without obstructive sleep apnea. Am J Med Genet A (2017) 0.75
The DNA sequence of human chromosome 21. Nature (2000) 10.66
[Study of somatic chromosomes from 9 mongoloid children]. C R Hebd Seances Acad Sci (1959) 6.88
Recent advances in craniofacial morphogenesis. Dev Dyn (2006) 3.50
The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of Down syndrome. Genet Med (2009) 2.83
Precision and error of three-dimensional phenotypic measures acquired from 3dMD photogrammetric images. Am J Med Genet A (2005) 2.39
Improved national prevalence estimates for 18 selected major birth defects--United States, 1999-2001. MMWR Morb Mortal Wkly Rep (2006) 2.33
Anthropometric precision and accuracy of digital three-dimensional photogrammetry: comparing the Genex and 3dMD imaging systems with one another and with direct anthropometry. J Craniofac Surg (2006) 2.25
Cranial skeletal biology. Nature (2003) 2.18
Molecular interactions coordinating the development of the forebrain and face. Dev Biol (2005) 2.12
A zone of frontonasal ectoderm regulates patterning and growth in the face. Development (2003) 2.04
Validity and reliability of craniofacial anthropometric measurement of 3D digital photogrammetric images. Cleft Palate Craniofac J (2008) 2.02
Ohnologs in the human genome are dosage balanced and frequently associated with disease. Proc Natl Acad Sci U S A (2010) 2.02
A SHH-responsive signaling center in the forebrain regulates craniofacial morphogenesis via the facial ectoderm. Development (2008) 1.93
Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. Gene (2003) 1.93
Wnt signaling mediates regional specification in the vertebrate face. Development (2007) 1.89
Down syndrome--recent progress and future prospects. Hum Mol Genet (2009) 1.85
Comparison between traditional 2-dimensional cephalometry and a 3-dimensional approach on human dry skulls. Am J Orthod Dentofacial Orthop (2004) 1.77
Too much of a good thing: mechanisms of gene action in Down syndrome. Trends Genet (2001) 1.72
Down syndrome--a disruption of homeostasis. Am J Med Genet (1983) 1.49
Anthropometric craniofacial pattern profiles in Down syndrome. Am J Med Genet (1993) 1.36
Beyond race or ethnicity and socioeconomic status: predictors of prenatal testing for Down syndrome. Obstet Gynecol (2006) 1.36
Phenotypic integration of neurocranium and brain. J Exp Zool B Mol Dev Evol (2006) 1.24
FGF signals from the nasal pit are necessary for normal facial morphogenesis. Dev Biol (2008) 1.23
Genetic interactions between Pax9 and Msx1 regulate lip development and several stages of tooth morphogenesis. Dev Biol (2010) 1.21
Signaling by bone morphogenetic proteins directs formation of an ectodermal signaling center that regulates craniofacial development. Dev Biol (2007) 1.20
Spatial and temporal analysis of gene expression during growth and fusion of the mouse facial prominences. PLoS One (2009) 1.11
Msx1 and Dlx5 act independently in development of craniofacial skeleton, but converge on the regulation of Bmp signaling in palate formation. Mech Dev (2005) 1.09
Inactivation of Msx1 and Msx2 in neural crest reveals an unexpected role in suppressing heterotopic bone formation in the head. Dev Biol (2010) 1.03
A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog. Mech Dev (2008) 1.01
A quantitative study of the face in Down's syndrome. Am J Orthod (1975) 0.95
Craniofacial complex in the trisomy 21 syndrome (Down's syndrome). Arch Oral Biol (1971) 0.92
Morphological integration of the skull in craniofacial anomalies. Orthod Craniofac Res (2009) 0.91
Amplified developmental instability in Down's syndrome. Ann Hum Genet (1975) 0.88
Looking different: understanding diversity in facial form. Am J Med Genet A (2006) 0.87
The palate and Down's syndrome. N Engl J Med (1967) 0.84
Surface anatomy of the face in Down's syndrome: linear and angular measurements in the craniofacial regions. J Craniofac Surg (2001) 0.83
Developmental instability of the cerebellum and its relevance to Down syndrome. J Neural Transm Suppl (2001) 0.83
Craniofacial development in patients with Down's syndrome from birth to 14 years of age. Eur J Orthod (1986) 0.83
Soft tissue facial anthropometry in Down syndrome subjects. J Craniofac Surg (2004) 0.83
Trisomy 21 and Down syndrome: a short review. Braz J Biol (2008) 0.82
Soft tissue facial angles in Down's syndrome subjects: a three-dimensional non-invasive study. Eur J Orthod (2005) 0.82
Surface anatomy of the face in Down's syndrome: age-related changes of anthropometric proportion indices in the craniofacial regions. J Craniofac Surg (2002) 0.82
Three-dimensional assessment of nose and lip morphology in subjects with down syndrome. Ann Plast Surg (2004) 0.80
Surface anatomy of the face in Down's syndrome: anthropometric proportion indices in the craniofacial regions. J Craniofac Surg (2001) 0.80
Dimensional and proportional characteristics of the face in Down's syndrome. J Dent Handicap (1979) 0.80
Frontal nasal prominence expression driven by Tcfap2a relies on a conserved binding site for STAT proteins. Dev Dyn (2006) 0.80
A twin study of palatal dimensions partitioning genetic and environmental contributions to variability. Angle Orthod (1969) 0.76
Abnormal measurements and disproportions in the face of Down's syndrome patients: preliminary report of an anthropometric study. Plast Reconstr Surg (1985) 0.76
The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet (2004) 9.37
Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome. Nature (2008) 2.71
Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. Genome Res (2004) 2.29
Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1. Cancer Res (2003) 1.93
Global disruption of the cerebellar transcriptome in a Down syndrome mouse model. Hum Mol Genet (2003) 1.80
Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model. Sci Transl Med (2013) 1.70
Genetic modifiers predisposing to congenital heart disease in the sensitized Down syndrome population. Circ Cardiovasc Genet (2012) 1.57
Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice. Hum Mol Genet (2007) 1.57
Defective cerebellar response to mitogenic Hedgehog signaling in Down [corrected] syndrome mice. Proc Natl Acad Sci U S A (2006) 1.47
The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. J Neurosci (2009) 1.46
Understanding the basis for Down syndrome phenotypes. PLoS Genet (2006) 1.41
Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome. Am J Med Genet (2002) 1.39
Genetic determinants influencing the response to injury, inflammation, and sepsis. Shock (2005) 1.35
Hippocampal hypocellularity in the Ts65Dn mouse originates early in development. Brain Res (2006) 1.31
Trisomy 21 and early brain development. Trends Neurosci (2011) 1.28
Development and validation of the Arizona Cognitive Test Battery for Down syndrome. J Neurodev Disord (2010) 1.15
Down syndrome: from understanding the neurobiology to therapy. J Neurosci (2010) 1.13
Genetic contribution to the septic response in a mouse model. Shock (2002) 1.08
Perinatal loss of Ts65Dn Down syndrome mice. Genetics (2005) 1.05
Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer. Jpn J Cancer Res (2002) 1.05
The use of mouse models to understand and improve cognitive deficits in Down syndrome. Dis Model Mech (2011) 1.05
Gene expression variation in Down's syndrome mice allows prioritization of candidate genes. Genome Biol (2007) 1.04
A quantitative trait loci analysis to map genes involved in lipopolysaccharide-induced inflammatory response: identification of macrophage scavenger receptor 1 as a candidate gene. J Immunol (2006) 1.02
Effects of aneuploidy on skull growth in a mouse model of Down syndrome. J Anat (2007) 1.02
A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog. Mech Dev (2008) 1.01
An excess of deleterious variants in VEGF-A pathway genes in Down-syndrome-associated atrioventricular septal defects. Am J Hum Genet (2012) 1.01
PCR prescreen for genotyping the Ts65Dn mouse model of Down syndrome. Biotechniques (2010) 0.98
Comparative genomic sequence analysis of the human chromosome 21 Down syndrome critical region. Genome Res (2002) 0.94
Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression. Mol Cancer (2005) 0.94
What are genes "for" or where are traits "from"? What is the question? Bioessays (2009) 0.94
Differential effects of trisomy on brain shape and volume in related aneuploid mouse models. Am J Med Genet A (2007) 0.93
Increased survival following tumorigenesis in Ts65Dn mice that model Down syndrome. Cancer Res (2011) 0.93
Developmental aspects of the upper airway: report from an NHLBI Workshop, March 5-6, 2009. Proc Am Thorac Soc (2009) 0.92
The effects of piracetam on cognitive performance in a mouse model of Down's syndrome. Physiol Behav (2002) 0.91
A Sonic hedgehog (Shh) response deficit in trisomic cells may be a common denominator for multiple features of Down syndrome. Prog Brain Res (2012) 0.87
Microstructure of trabecular bone in a mouse model for Down syndrome. Anat Rec (Hoboken) (2007) 0.85
Down syndrome: national conference on patient registries, research databases, and biobanks. Mol Genet Metab (2011) 0.85
IL-10 plasma levels are elevated after LPS injection in splenectomized A/J mice. J Surg Res (2005) 0.82
Complex contributions of Ets2 to craniofacial and thymus phenotypes of trisomic "Down syndrome" mice. Am J Med Genet A (2009) 0.82
Size does not always matter: Ts65Dn Down syndrome mice show cerebellum-dependent motor learning deficits that cannot be rescued by postnatal SAG treatment. J Neurosci (2013) 0.81
Protection from lethal endotoxic shock after testosterone depletion is linked to chromosome X. Shock (2005) 0.81
Increased male reproductive success in Ts65Dn "Down syndrome" mice. Mamm Genome (2010) 0.80
Allelic Interaction between CRELD1 and VEGFA in the Pathogenesis of Cardiac Atrioventricular Septal Defects. AIMS Genet (2014) 0.80
Trisomy 21 and facial developmental instability. Am J Phys Anthropol (2013) 0.79
Long-range chromosomal engineering is more efficient in vitro than in vivo. Transgenic Res (2005) 0.78
Assessing cognitive improvement in people with Down syndrome: important considerations for drug-efficacy trials. Handb Exp Pharmacol (2015) 0.78
Functional genomics: a time and place for every gene. Nature (2002) 0.75
How are we made?: Even well-controlled experiments show the complexity of our traits. Evol Anthropol (2015) 0.75
Genetic and comparative mapping of genes dysregulated in mouse hearts lacking the Hand2 transcription factor gene. Genomics (2002) 0.75
Meeting Report: 15th International Mouse Genome Conference. Mamm Genome (2002) 0.75